chrX-118392841-G-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_019045.5(WDR44):ā€‹c.396G>Cā€‹(p.Glu132Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,210,459 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.0000089 ( 0 hom., 0 hem., cov: 24)
Exomes š‘“: 0.000021 ( 0 hom. 11 hem. )

Consequence

WDR44
NM_019045.5 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.877
Variant links:
Genes affected
WDR44 (HGNC:30512): (WD repeat domain 44) This gene encodes a protein that interacts with the small GTPase rab11. A similar protein in rat binds the GTP-containing active form of rab11. This protein may play a role in endosome recycling. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.055864483).
BS2
High Hemizygotes in GnomAdExome4 at 11 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
WDR44NM_019045.5 linkuse as main transcriptc.396G>C p.Glu132Asp missense_variant 4/20 ENST00000254029.8
WDR44NM_001184965.2 linkuse as main transcriptc.396G>C p.Glu132Asp missense_variant 4/20
WDR44NM_001184966.1 linkuse as main transcriptc.321G>C p.Glu107Asp missense_variant 3/18
WDR44XM_011531353.4 linkuse as main transcriptc.321G>C p.Glu107Asp missense_variant 3/19

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
WDR44ENST00000254029.8 linkuse as main transcriptc.396G>C p.Glu132Asp missense_variant 4/201 NM_019045.5 P1Q5JSH3-1

Frequencies

GnomAD3 genomes
AF:
0.00000891
AC:
1
AN:
112286
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34426
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000218
AC:
4
AN:
183238
Hom.:
0
AF XY:
0.0000295
AC XY:
2
AN XY:
67792
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000489
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000209
AC:
23
AN:
1098173
Hom.:
0
Cov.:
31
AF XY:
0.0000303
AC XY:
11
AN XY:
363527
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000284
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000369
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000178
Gnomad4 OTH exome
AF:
0.0000434
GnomAD4 genome
AF:
0.00000891
AC:
1
AN:
112286
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34426
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000203
Hom.:
1
ExAC
AF:
0.0000165
AC:
2
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 12, 2021The c.396G>C (p.E132D) alteration is located in exon 4 (coding exon 4) of the WDR44 gene. This alteration results from a G to C substitution at nucleotide position 396, causing the glutamic acid (E) at amino acid position 132 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
12
DANN
Uncertain
0.98
DEOGEN2
Benign
0.11
.;T;.
FATHMM_MKL
Benign
0.48
N
LIST_S2
Benign
0.71
T;T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.056
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
.;L;L
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.26
N;N;N
REVEL
Benign
0.099
Sift
Benign
0.36
T;T;T
Sift4G
Benign
0.54
T;T;T
Polyphen
0.0020, 0.0010
.;B;B
Vest4
0.086
MutPred
0.13
.;Gain of phosphorylation at T133 (P = 0.1701);Gain of phosphorylation at T133 (P = 0.1701);
MVP
0.27
MPC
0.18
ClinPred
0.072
T
GERP RS
4.4
Varity_R
0.079
gMVP
0.067

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs771542506; hg19: chrX-117526804; API